Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis

Journal of Pediatric Surgery

Volumn 35, Issue 3, 2000, Pages 473-479

  Schaefer, Jochen T ^a   Barthlen, Winfried ^a   Schweizer, Paul ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; CD95 ligand; CD95 receptor; Ceramide; Neuroblastoma

Indexed keywords

ANTIBODY; CERAMIDE; DNA; FAS ANTIGEN; PROPIDIUM IODIDE; RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSCOPY; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0034063953     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(00)90217-3     Document Type: Article

References (26)

1. Evans AE, Baum E. Chard R: Do infant with stage 4S neuroblastoma need treatment? Arch Dis Child 56:271-274, 1981
2. Haas D, Blin AR, Miller C, et al: Complete pathologic maturation and regression of stage 4S neuroblastoma without treatment. Cancer 62:818-825, 1988
3. Iwata M, Koshinaga T, Okabe I, et al: Biological characteristics of neuroblastoma with spontaneous tumor reduction: A case report. J Pediatr Surg 30:722-723, 1995
4. Nikkhah G, Tonn JC, Hoffmann O, et al: The MTT assay for chemosensitivity testing of human tumors of the central nervous system. J Neurooncol 13:1-11, 1992
5. Pritchard J. Hickman JA: Why does stage 4s neuroblastoma regress spontaneously? Lancet 344:869-870, 1994
6. Bertliold F: Overview: Biology of neuroblastoma, in Pochedly C (ed): Neuroblastoma: Tumor Biology and Therapy. Boca Raton, FL. CRC Press. 1990, pp 1-30
7. Ellis RE, Yuan JY, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663-698. 1991
8. Kerr JFR, Winterford CM. Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 73:2013-2026. 1994
9. Al-Rubeai M: Apoptosis and cell culture technology. Adv Biochem Eng Biotechnol 59:225-249. 1998
10. Itoh N, Yonehara S, Ishii A, et al: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
11. Collins MKL, Marvel J, Malde P. et al: Imerleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 176:1043-1051. 1992
12. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456. 1995
13. Fulda S, Sieverts H, Friesen C. et al: The CD95 (Apo-I/Fas) system mediates drug induced apoptosis in neuroblastoma cells. Cancer Res 57:3823-3829, 1997
14. Hannun YA: Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859, 1996
15. Gulbins E, Bissonette R, Mahboubi A. et al: Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2:341-351. 1995
16. Susin SA, Zamzami N, Castedo M. et al: The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J Exp Med 186:25-37, 1997
17. Friesen C, Fulda S, Debatin KM: Deficient activation of the CD95 (Apo-1/Fas) system in drug-resistant cells. Leukemia 11:1833-1841, 1997
18. Los M, Herr I, Friesen C. et al: Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases(ICE/Ced-3 proteases). Blood 90:3118-3129, 1997
19. Nicholson DW, Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci 22:299-306. 1997
20. Irmler M, Thome M, Hahne M, et al: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997
21. Nicoletti I, Migliorati G, Pagliacci MC, et al: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
22. Scaffidi C, Fulda S, Srinivasan A, et al: Two CD95 (Apo-1/Fas) signaling pathways. EMBO J 17:1675-1687, 1998
23. Brenner B, Ferlinz K, Grassmé H. et al: Fas/CD95/Apo-1 activates the acidic sphingomyelinase via caspases. Cell Death Differ 5:29-37, 1998
24. Peter ME, Scaffidi C, Medema JP, et al: The death receptors. Results Probl Cell Differ 23:25-63, 1999
25. Boldin MP, Goncharov TM, Goltsev YV, et al: Involvement of MACH, a novel MORTI/FADD-interacting protease in Fas/APO-I-and TNF-receptor-induced cell death. Cell 85:803-815, 1996
26. Weller M, Frei K, Groscurth P, et al: Anti-Fas/Apol antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954-964, 1994